Medicine and Dentistry
Acute Leukemia
6%
Acute Lymphoblastic Leukemia
14%
Age
15%
Analysis
15%
Autologous Stem Cell Transplantation
10%
Busulfan
6%
Case Report
10%
Cells
8%
Central Nervous System
7%
Chemotherapy
18%
Child
27%
Childhood
10%
Childhood Cancer
7%
Combination Therapy
23%
Complication
10%
Cyclophosphamide
14%
Cytomegalovirus Infection
7%
Diagnosis
13%
Donor
15%
Event Free Survival
11%
Experience
10%
Follow up
11%
Germinoma
10%
Hematopoietic Stem Cell
6%
Hematopoietic Stem Cell Transplantation
25%
Hemophagocytic Syndrome
6%
Hepatic Veno-Occlusive Disease
7%
High Dose Chemotherapy
14%
Hospital
9%
Imatinib
6%
Inpatient
12%
Lymphoma
7%
Overall Survival
17%
Patient
100%
Pediatrics Patient
29%
Posttransplant Lymphoproliferative Disease
6%
Prospective Study
7%
Radiation Therapy
9%
Relapse
6%
Retinoblastoma
6%
Retrospective Study
11%
Shear Wave Elastography
6%
Spontaneous Remission
8%
Stem Cell Transplant
6%
Survival Rate
19%
T Cell
6%
Toxicity
8%
Transplantation
12%
Vein Occlusion
6%
Young Adult
6%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
8%
Busulfan
10%
Chemotherapy
9%
Fludarabine
6%
Imatinib
6%
Malignant Neoplasm
5%
Neutropenia
8%
Pharmacodynamics
5%
Pharmacokinetics
14%
Solid Malignant Neoplasm
5%
Toxicity
9%